The Future of Bioprinting for Healthcare and Pharmaceutical

As 3D printing technologies keep improving and enhancement in materials helping industries, such as aerospace, manufacturing, automotive, electronics and many more, with applications that suit to their need.

Bioprinting is an extension of 3D printing, an additive manufacturing process, building layer by layer, where biomaterials such as cells and growth factors are combines to create tissue-like structure.

Bioprinting for healthcare and medical, has also been improving and creating opportunity to generate patient-specific tissue, living tissue, bone, etc. for healthcare and pharmaceutical.

3D Systems, co-founded by the inventor of 3D printing, Chuck Hull – who files patent for Stereolithography Apparatus (SLA) in 1983, create new approaches and processes for product development, parts manufacturing and personalized healthcare through additive manufacturing solutions.

Now leveraging this experience to innovate bioprinting technologies to transform patient care. Allevi Inc, part of 3D Systems in May 2021, provides a robust set of bioprinting solutions to researchers and industry giants in hundreds of labs globally.

Allevi desktop 3D bioprinters are versatile, powerful and easy-to-use bioprinters on the market with access to wide range of biomaterials – bioinks, bioink additives, cells, reagents and consumables and intuitive software interface.

Bioprinting allows researchers to model disease, create custom 3D tissue, and study the body outside the body with a level of control and repeatability. 3D bioprinting for pharmaceutical development offers a means of testing drugs faster. The development for personalized and regenerative medicine continue to grow and it gives doctors and researchers the tools to better target treatments and improve patient outcomes.

Rokit Healthcare is a 4D Bioprinting and Biotechnology company based in South Korea is committed to bettering humanity to the field of regenerative medicine.

4D bioprinting is the automated and computer-aided layer by layer deposition of biomaterials, cells, stem cell growth factors, and biocompatible polymers for manufacturing of functional human tissues or organs.

The development of 4D bioprinting for stem cell therapy has the ability to customize scaffold shapes and cell seeding patterns, combined with the ability to use pluripotent stem cells. Using 4D bioprinter and components of dermal matric, give the possibilities to create artificial human skin. 4D bioprinting also helps to replicate the naturally occurring architectural complexities in craniofacial tissues and to develop novel scaffold biomaterials for bone and oral tissue regeneration.